PhaseII Study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis)
Phase 2
- Conditions
- Enthesopathy (Lateral Epicondylitis)
- Registration Number
- JPRN-UMIN000008218
- Lead Sponsor
- KAKEN PHARMACEUTICAL CO., LTD/SEIKAGAKU CORPORATIO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who received local injection or steroid topical treatment at the arm affected with lateral epicondylitis within 2 weeks before the first administration. 2.Patients with pain due to complication other than lateral epicondylitis around the affected site. 3.Patients with infectious risk at the administration site due to skin disease or infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy Outcome; Change of Visual Analogue Scale (VAS) of pain at final evaluation.
- Secondary Outcome Measures
Name Time Method Efficacy Outcomes; Roles and Maudsley score Safety Outcomes; Adverse events Laboratory tests